These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34436255)

  • 1. Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model.
    Alsaidi S; Cornejal N; Mahoney O; Melo C; Verma N; Bonnaire T; Chang T; O'Keefe BR; Sailer J; Zydowsky TM; Teleshova N; Romero JAF
    Mar Drugs; 2021 Jul; 19(8):. PubMed ID: 34436255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta.
    Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.
    Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W
    mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit.
    Cai Y; Xu W; Gu C; Cai X; Qu D; Lu L; Xie Y; Jiang S
    Virol Sin; 2020 Dec; 35(6):857-860. PubMed ID: 33052520
    [No Abstract]   [Full Text] [Related]  

  • 5. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
    Morokutti-Kurz M; Fröba M; Graf P; Große M; Grassauer A; Auth J; Schubert U; Prieschl-Grassauer E
    PLoS One; 2021; 16(2):e0237480. PubMed ID: 33596218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures.
    Schütz D; Conzelmann C; Fois G; Groß R; Weil T; Wettstein L; Stenger S; Zelikin A; Hoffmann TK; Frick M; Müller JA; Münch J
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L750-L756. PubMed ID: 33561380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2.
    Jang Y; Shin H; Lee MK; Kwon OS; Shin JS; Kim YI; Kim CW; Lee HR; Kim M
    Sci Rep; 2021 Jan; 11(1):821. PubMed ID: 33436985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.
    Levendosky K; Mizenina O; Martinelli E; Jean-Pierre N; Kizima L; Rodriguez A; Kleinbeck K; Bonnaire T; Robbiani M; Zydowsky TM; O'Keefe BR; Fernández-Romero JA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7290-8. PubMed ID: 26369967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2.
    Song S; Peng H; Wang Q; Liu Z; Dong X; Wen C; Ai C; Zhang Y; Wang Z; Zhu B
    Food Funct; 2020 Sep; 11(9):7415-7420. PubMed ID: 32966484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.
    Bansal S; Jonsson CB; Taylor SL; Figueroa JM; Dugour AV; Palacios C; Vega JC
    PLoS One; 2021; 16(11):e0259943. PubMed ID: 34797868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
    Idrees M; Khan S; Memon NH; Zhang Z
    Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.
    Jang Y; Shin JS; Lee MK; Jung E; An T; Kim UI; Kim K; Kim M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2.
    Kiani P; Scholey A; Dahl TA; McMann L; Iversen JM; Verster JC
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33810356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-SARS-CoV-2 Activity of Polysaccharides Extracted from
    Jousselin C; Pliego-Cortés H; Damour A; Garcia M; Bodet C; Robledo D; Bourgougnon N; Lévêque N
    Mar Drugs; 2023 Jun; 21(6):. PubMed ID: 37367673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
    Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle East respiratory syndrome coronavirus infection is inhibited by griffithsin.
    Millet JK; Séron K; Labitt RN; Danneels A; Palmer KE; Whittaker GR; Dubuisson J; Belouzard S
    Antiviral Res; 2016 Sep; 133():1-8. PubMed ID: 27424494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review.
    Frediansyah A
    Clin Epidemiol Glob Health; 2021; 12():100826. PubMed ID: 34222718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses.
    Ahn DG; Yoon GY; Lee S; Ku KB; Kim C; Kim KD; Kwon YC; Kim GW; Kim BT; Kim SJ
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of marine species-derived bioactive agents in the management of SARS-CoV-2 infection.
    Asif M; Saleem M; Yaseen HS; Yehya AH; Saadullah M; Zubair HM; Oon CE; Khaniabadi PM; Khalid SH; Khan IU; Mahrukh
    Future Microbiol; 2021 Nov; 16(16):1289-1301. PubMed ID: 34689597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad-spectrum in vitro activity and in vivo efficacy of the antiviral protein griffithsin against emerging viruses of the family Coronaviridae.
    O'Keefe BR; Giomarelli B; Barnard DL; Shenoy SR; Chan PK; McMahon JB; Palmer KE; Barnett BW; Meyerholz DK; Wohlford-Lenane CL; McCray PB
    J Virol; 2010 Mar; 84(5):2511-21. PubMed ID: 20032190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.